JP2020535832A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020535832A5 JP2020535832A5 JP2020519092A JP2020519092A JP2020535832A5 JP 2020535832 A5 JP2020535832 A5 JP 2020535832A5 JP 2020519092 A JP2020519092 A JP 2020519092A JP 2020519092 A JP2020519092 A JP 2020519092A JP 2020535832 A5 JP2020535832 A5 JP 2020535832A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- tcr
- human
- antigen
- constant region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023220106A JP7747724B2 (ja) | 2017-10-05 | 2023-12-26 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762568339P | 2017-10-05 | 2017-10-05 | |
| US62/568,339 | 2017-10-05 | ||
| PCT/US2018/052432 WO2019070435A1 (en) | 2017-10-05 | 2018-09-24 | METHODS FOR SELECTIVE EXPANSION OF CELLS EXPRESSING A TCR WITH A CONSTANT MURINE REGION |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023220106A Division JP7747724B2 (ja) | 2017-10-05 | 2023-12-26 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020535832A JP2020535832A (ja) | 2020-12-10 |
| JP2020535832A5 true JP2020535832A5 (https=) | 2021-11-04 |
Family
ID=63841049
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020519092A Pending JP2020535832A (ja) | 2017-10-05 | 2018-09-24 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
| JP2023220106A Active JP7747724B2 (ja) | 2017-10-05 | 2023-12-26 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023220106A Active JP7747724B2 (ja) | 2017-10-05 | 2023-12-26 | マウス定常領域を伴うｔｃｒを発現する細胞を選択的に増幅するための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12227554B2 (https=) |
| EP (2) | EP3692140B1 (https=) |
| JP (2) | JP2020535832A (https=) |
| KR (1) | KR102757789B1 (https=) |
| CN (1) | CN111417720B (https=) |
| AU (1) | AU2018345400B2 (https=) |
| CA (1) | CA3077595A1 (https=) |
| ES (1) | ES2960313T3 (https=) |
| FI (1) | FI3692140T3 (https=) |
| IL (1) | IL273698B2 (https=) |
| MA (1) | MA50748A (https=) |
| SG (1) | SG11202003112QA (https=) |
| WO (1) | WO2019070435A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220195006A1 (en) * | 2020-12-22 | 2022-06-23 | Neogene Therapeutics B.V. | Peptide markers to track genetically engineered cells |
| WO2022183167A1 (en) | 2021-02-25 | 2022-09-01 | Alaunos Therapeutics, Inc. | Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof |
| US20250145950A1 (en) * | 2022-02-01 | 2025-05-08 | Alaunos Therapeutics, Inc. | Methods for Activation and Expansion of T Cells |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0571613B1 (en) | 1991-12-13 | 2003-09-17 | Xoma Corporation | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| JPH11512284A (ja) | 1995-09-05 | 1999-10-26 | ザ ジェネラル ホスピタル コーポレイション | 単クローン性リンパ球及び利用方法 |
| DE19905048A1 (de) | 1999-02-08 | 2000-08-10 | Gsf Forschungszentrum Umwelt | Verwendung depletorisch oder mitogen wirkender Antikörper in der Immuntherapie |
| JP2003274960A (ja) | 2000-02-03 | 2003-09-30 | Japan Science & Technology Corp | 可溶性ｔ細胞受容体タンパク質およびその作成方法 |
| JP2003276960A (ja) * | 2002-03-26 | 2003-10-02 | Mitsubishi Electric Corp | エレベーター制御システム |
| US8034334B2 (en) | 2002-09-06 | 2011-10-11 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy |
| KR101131297B1 (ko) * | 2003-11-10 | 2012-03-30 | 알토 바이오사이언스 코포레이션 | 가용성 티씨알 분자 및 이용 방법 |
| CA2651174A1 (en) * | 2006-05-03 | 2007-11-15 | Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services | Chimeric t cell receptors and related materials and methods of use |
| WO2008089053A2 (en) | 2007-01-12 | 2008-07-24 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Gp100-specific t cell receptors and related materials and methods of use |
| WO2010088160A1 (en) | 2009-01-28 | 2010-08-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors and related materials and methods of use |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| CN103124740B (zh) | 2010-09-21 | 2015-09-02 | 美国卫生和人力服务部 | 抗-ssx-2t细胞受体和相关材料及使用方法 |
| US20120244133A1 (en) | 2011-03-22 | 2012-09-27 | The United States of America, as represented by the Secretary, Department of Health and | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| EP2852613B1 (en) | 2012-05-22 | 2019-01-23 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Murine anti-ny-eso-1 t cell receptors |
| KR102480188B1 (ko) * | 2012-09-14 | 2022-12-21 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | Mhc ii형 제한된 mage-a3을 인식하는 t 세포 수용체 |
| ES2745472T3 (es) * | 2013-07-15 | 2020-03-02 | The U S A As Represented By The Secretary Department Of Health And Human Services Office Of Tech Tra | Receptores de células T anti-virus del papiloma humano 16 E6 |
| MX375379B (es) * | 2014-05-29 | 2025-03-06 | Us Health | Receptores de celulas t anti - papilomavirus 16 e7 humano. |
| JP6599450B2 (ja) * | 2014-10-02 | 2019-10-30 | アメリカ合衆国 | がん特異的突然変異に対し抗原特異性を有するｔ細胞を単離する方法 |
| WO2016079333A1 (en) | 2014-11-20 | 2016-05-26 | Umc Utrecht Holding B.V. | Use of antibodies for enrichment of engineered t cells with exogenous immune receptors and antibodies for use in depletion of engineered t cells |
| CN118994363A (zh) | 2014-11-26 | 2024-11-22 | 美国卫生和人力服务部 | 抗突变的kras的t细胞受体 |
| ES2879287T3 (es) | 2015-09-15 | 2021-11-22 | Us Health | Receptores de células T que reconocen KRAS mutado restringido a HLA-cw8 |
| CA3021898A1 (en) | 2016-04-26 | 2017-11-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-kk-lc-1 t cell receptors |
| HRP20221183T1 (hr) | 2016-08-02 | 2022-12-09 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | T-stanični receptori anti-kras-g12d |
-
2018
- 2018-09-24 AU AU2018345400A patent/AU2018345400B2/en active Active
- 2018-09-24 MA MA050748A patent/MA50748A/fr unknown
- 2018-09-24 US US16/652,948 patent/US12227554B2/en active Active
- 2018-09-24 SG SG11202003112QA patent/SG11202003112QA/en unknown
- 2018-09-24 ES ES18786145T patent/ES2960313T3/es active Active
- 2018-09-24 EP EP18786145.5A patent/EP3692140B1/en active Active
- 2018-09-24 JP JP2020519092A patent/JP2020535832A/ja active Pending
- 2018-09-24 EP EP23185846.5A patent/EP4269595A3/en active Pending
- 2018-09-24 FI FIEP18786145.5T patent/FI3692140T3/fi active
- 2018-09-24 WO PCT/US2018/052432 patent/WO2019070435A1/en not_active Ceased
- 2018-09-24 KR KR1020207012314A patent/KR102757789B1/ko active Active
- 2018-09-24 IL IL273698A patent/IL273698B2/en unknown
- 2018-09-24 CA CA3077595A patent/CA3077595A1/en active Pending
- 2018-09-24 CN CN201880076862.9A patent/CN111417720B/zh active Active
-
2023
- 2023-12-26 JP JP2023220106A patent/JP7747724B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lonez et al. | Allogeneic CAR-T therapy technologies: has the promise been met? | |
| Kervevan et al. | Role of CD4+ T cells in the control of viral infections: recent advances and open questions | |
| Agac et al. | Host responses to respiratory syncytial virus infection | |
| Palatella et al. | The dark side of Tregs during aging | |
| JP2021511790A5 (https=) | ||
| Zhang et al. | Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo | |
| JP2016539929A5 (https=) | ||
| JP2019536461A5 (https=) | ||
| JP2016509840A5 (https=) | ||
| JP2020535832A5 (https=) | ||
| JP2019516754A5 (https=) | ||
| JP2004536615A5 (https=) | ||
| Qiu et al. | Listeria monocytogenes: a model pathogen continues to refine our knowledge of the CD8 T cell response | |
| JP2010505830A5 (https=) | ||
| WO2016165632A1 (zh) | 一种能联合免疫细胞增强肿瘤杀伤能力的双特异性抗体及其制备方法和应用 | |
| JP2018522072A5 (https=) | ||
| JP2019520823A5 (https=) | ||
| CN102911918A (zh) | 一种基因工程细胞及其在nk细胞扩增中的应用 | |
| JP2012505665A5 (https=) | ||
| JP2011519869A5 (https=) | ||
| ATE525908T1 (de) | Einstufiges schnellverfahren zurherstellung eines antigenbeladenen dendritenzellimpfstoffs aus vorstufen | |
| Forrest et al. | NK cell memory to cytomegalovirus: implications for vaccine development | |
| JP2017508523A5 (https=) | ||
| JP2013505296A5 (https=) | ||
| DE60332377D1 (de) | Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden |